IMMIX BIOPHARMA, INC.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $19.9M
Liabilities Breakdown FY2023
Total Liabilities: $3.7M
Asset Breakdown
Total Assets: $19.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $17.5M | 87.9% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $50.2K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $2.4M | 11.9% |
Liabilities Breakdown
Total Liabilities: $3.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.4M | 38.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.3M | 61.5% |